PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.

Boehringer Ingelheim

Status: Completed

Conditions: HIV Infections

Study type: Observational

Funder types: Industry

Identifiers

NCT00736502

1100.1527

Details and patient eligibility

About

The aim of this trial is to evaluate the safety and virological and immunological efficacy of Viramune® on a background of different antiretroviral drug combinations.

Enrollment: 280 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

The inclusion criteria follow the same criteria which are describe in the newest SPC.

Exclusion criteria

The exclusion criteria follow the same criteria which are describe in the newest SPC.

Trial design

280 participants in 1 patient group

Patients HIV-1 positive